Celgene Reaches Analyst Target Price
June 24, 2019 at 08:28 AM EDT
In recent trading, shares of Celgene Corp (CELG) have crossed above the average analyst 12-month target price of $98.80, changing hands for $98.91/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..